Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-27 6:43 pm Purchase | 2025-02-10 | 13G | ORUKA THERAPEUTICS INC ORKA | Venrock Healthcare Capital Partners III, L.P. | 4,148,428 11.100% | 606,487![]() (+17.12%) | Filing History |
| 2024-11-21 6:30 pm Purchase | 2024-11-19 | 13D | ORUKA THERAPEUTICS INC ORKA | Fairmount Funds Management LLC | 7,941,690 19.990% | 17![]() (+0.00%) | Filing History |
| 2024-11-14 7:38 pm Purchase | 2024-09-30 | 13G | ORUKA THERAPEUTICS INC ORKA | Avidity Partners Management LP | 790,926 2.300% | 707,593![]() (+849.11%) | Filing History |
| 2024-11-14 5:49 pm Purchase | 2024-09-30 | 13G | ORUKA THERAPEUTICS INC ORKA | Venrock Healthcare Capital Partners III, L.P. | 3,541,941 9.990% | 3,479,052![]() (+5532.05%) | Filing History |
| 2024-11-14 12:04 pm Sale | 2024-09-30 | 13G | ORUKA THERAPEUTICS INC ORKA | Allostery Investments LP | 43,557 0.300% | -45,194![]() (-50.92%) | Filing History |
| 2024-11-14 09:56 am Purchase | 2024-09-30 | 13G | ORUKA THERAPEUTICS INC ORKA | JANUS HENDERSON GROUP Ltd. JHG | 236,116 0.700% | 112,571![]() (+91.12%) | Filing History |
| 2024-10-22 4:15 pm Purchase | 2024-10-22 | 13D | ORUKA THERAPEUTICS INC ORKA | Adage Capital Management, L.P. | 175,000 0.500% | 75,000![]() (+75.00%) | Filing History |
| 2024-10-07 11:37 am Purchase | 2024-10-04 | 13G | ORUKA THERAPEUTICS INC ORKA | FMR LLC | 5,512,300 15.345% | 5,512,300![]() (New Position) | Filing History |
| 2024-09-13 4:57 pm Purchase | 2024-09-11 | 13D | ORUKA THERAPEUTICS INC ORKA | Fairmount Funds Management LLC | 7,941,673 19.990% | 1,330,418![]() (+20.12%) | Filing History |
| 2024-09-06 5:08 pm Purchase | 2024-08-29 | 13D | ORUKA THERAPEUTICS INC ORKA | Fairmount Funds Management LLC | 6,611,255 19.990% | 6,611,255![]() (New Position) | Filing History |
| 2024-07-05 5:20 pm Purchase | 2024-07-02 | 13G | ARCA BIOPHARMA INC PAR $.0 ABIO | JANUS HENDERSON GROUP Ltd. JHG | 123,545 10.200% | 33,536![]() (+37.26%) | Filing History |
| 2024-04-29 7:28 pm Purchase | 2024-04-17 | 13G | ARCA BIOPHARMA INC PAR $.0 ABIO | Venrock Healthcare Capital Partners III, L.P. | 62,889 5.200% | 62,889![]() (New Position) | Filing History |
| 2024-04-15 5:29 pm Purchase | 2024-04-03 | 13G | ARCA BIOPHARMA INC PAR $.0 ABIO | Allostery Investments LP | 88,751 7.300% | 88,751![]() (New Position) | Filing History |
| 2024-04-11 09:51 am Purchase | 2024-04-03 | 13G | ARCA BIOPHARMA INC PAR $.0 ABIO | JANUS HENDERSON GROUP Ltd. JHG | 90,009 7.400% | 90,009![]() (New Position) | Filing History |
| 2024-04-09 8:57 pm Purchase | 2024-04-03 | 13G | ARCA BIOPHARMA INC PAR $.0 ABIO | Avidity Partners Management LP | 83,333 6.900% | 83,333![]() (New Position) | Filing History |
| 2024-04-05 7:38 pm Purchase | 2023-12-31 | 13G | ARCA BIOPHARMA INC PAR $.0 ABIO | Western Standard LLC | 117,512 9.800% | 38,826![]() (+49.34%) | Filing History |
| 2024-04-05 4:05 pm Purchase | 2024-04-03 | 13D | ARCA BIOPHARMA INC PAR $.0 ABIO | Adage Capital Management, L.P. | 100,000 8.280% | 100,000![]() (New Position) | Filing History |
| 2024-02-07 1:08 pm Sale | 2023-12-31 | 13G | ARCA BIOPHARMA INC PAR $.0 ABIO | BML Investment Partners, L.P. | 58,911 4.900% | -12,610![]() (-17.63%) | Filing History |
| 2023-09-11 4:01 pm Purchase | 2023-08-30 | 13G | ARCA BIOPHARMA INC PAR $.0 ABIO | Western Standard LLC | 78,686 6.600% | 78,686![]() (New Position) | Filing History |
| 2023-02-08 2:48 pm Purchase | 2023-02-08 | 13G | ARCA BIOPHARMA INC PAR $.0 ABIO | BML Investment Partners, L.P. | 71,521 5.950% | 8,033![]() (+12.65%) | Filing History |

